This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,998.87 and covers the delivery of Alfuzosin HCL ER 10 mg tablets to support healthcare programs within the U.S. military and federal government. The contract is a firm fixed-price delivery order with a completion date of July 3, 2024. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,786.17 firm fixed-price delivery order is for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,932.61 firm fixed-price delivery order is for alfuzosin HCL extended-release 10 mg tablets, with an ultimate completion date of October 30, 2024. The award is part of a larger, $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which...
This is a $25,460.19 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This federal contract award, with ID SPE2DB24D1021|SPE2DB24FERQX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,389.86, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed-price delivery order contract with a completion date of May 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,142.46 firm-fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. There was no set-aside designation for this contract....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCl ER 10 mg tablets. The delivery order is valued at $2,592.98 and has a period of performance through May 8, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order valued at $2,506.72 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 120 tablets of Alfuzosin HCl ER 10 mg. This award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in effect through December 2025. The contract does not have a set-aside designation and is intended to support military...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,643.52, is for the delivery of 4,563,062,995 units of the medication Alfuzosin HCL ER 10 mg Tablet in 100-count bottles. The contract has an ultimate completion date of December 12, 2023 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a $11,307.61 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The award is not a set-aside contract. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...